2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has rallied in the last two weeks and is back on track for a solid year of growth. 

Since July 24, Australia's benchmark index has climbed an impressive 5.2%. 

In fact, the ASX 200 hit a new all-time high during Wednesday's session. 

This has reignited some positive outlooks on ASX 200 shares. 

Two in particular have drawn positive ratings from the team at Bell Potter and Macquarie this week. 

Here's the latest from the broker. 

Young African Businesswoman Analyzing Data On Multiple Computer Screen In Office

SGH Ltd (ASX: SGH)

SGH is a diversified industrial and investment group, with interests in heavy-equipment sales, service and equipment hire, media and broadcasting, oil and gas, and developable property.

It has had a relatively flat year, down just 1% in 2026. 

However a new report from Bell Potter suggests that it could be a strong buy candidate. 

The broker said the ASX 200 company's mining outlook is improving. 

According to the report:

  • Mining equipment demand is showing positive signs.
  • Major suppliers Sandvik and Epiroc reported strong growth in new orders, which has historically been a good indicator for SGH's WesTrac business.
  • Equipment sales across manufacturers were mixed, but the increase in new orders suggests demand should remain healthy.
  • Australia's forecast for steady iron ore production growth over the next few years should support ongoing spending on mining equipment and maintenance.

The mining business remains solid, construction is slowing, and Boral has become the main earnings growth engine for SGH. Bell Potter expects only modest profit growth over the next couple of years but remains positive because of the company's strong cash flow, disciplined capital management, and shareholder returns.

Based on this guidance, the broker has a buy rating on this ASX 200 stock along with an increased price target of $51. 

From yesterday's closing price, this indicates a 10% upside. 

Life360 Inc (ASX: 360)

Life360 shares came under heavy pressure over the last 12 months as investors rotated out of the technology sector.

It remains down 25% in the last 12 months, however Bell Potter and Macquarie are anticipating a rebound. 

Macquarie has a $31.10 price target on this ASX 200 stock, while Bell Potter has a buy rating and $35.00 price target on the ASX tech stock. 

Bell Potter said: 

We see the stock as reasonable value trading on a 2027 EV/EBITDA multiple of c.25x which is a discount to the Technology One multiple of c.29x. We believe Life360 deserves to trade on a similar if not higher multiple than Technology One given it is global, a market leader and has higher forecast earnings growth over the next few years.

These targets suggest upside potential of 7% to 18%. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »